MERIEUX INACTIVATED RABIES VACCINE 2.5IU Powder for Injection with Diluent Australia - English - Department of Health (Therapeutic Goods Administration)

merieux inactivated rabies vaccine 2.5iu powder for injection with diluent

sanofi-aventis australia pty ltd - rabies virus, quantity: 2.5 iu - injection, powder for - excipient ingredients: albumin; neomycin - idications as at 12 july 2004: post exposure immunisation against rabies. pre-exposure immunisation in persons at special risk of contracting rabies.

Nobivac Rabies United Kingdom - English - VMD (Veterinary Medicines Directorate)

nobivac rabies

msd animal health uk limited - rabies virus - suspension for injection - inactivated viral vaccine - cats, dogs

Vanguard Rabies United Kingdom - English - VMD (Veterinary Medicines Directorate)

vanguard rabies

zoetis uk limited - rabies virus - suspension for injection - inactivated viral vaccine - cats, dogs

Canigen Rabies United Kingdom - English - VMD (Veterinary Medicines Directorate)

canigen rabies

msd animal health uk limited - rabies virus - suspension for injection - inactivated viral vaccine - cats, dogs

Versiguard Rabies Suspension for Injection United Kingdom - English - VMD (Veterinary Medicines Directorate)

versiguard rabies suspension for injection

zoetis uk limited - rabies virus - suspension for injection - inactivated viral vaccine - cats, cattle, dogs, ferrets, goats, horses, pigs, sheep

Versican Plus DHPPi/L4R European Union - English - EMA (European Medicines Agency)

versican plus dhppi/l4r

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Biocan Novel DHPPi L4R Formulation:   Each dose (1 mL) contains:   Canine Distemper Virus (CDV Bio 11/A strain)- 10^3.1 to 10^5.1 TCID50 Canine Parainfluenza Type 2 Virus (CPIV-2-Bio 15 strain)-- 10^3.1 to 10^5.1 TCID50 Canine Adenovirus Type 2 (CAV-2-Bio 13 strain)-10^3.6 to 10^5.3 TCID50 Canine Parvovirus Type 2b (CPV-2b Bio 12/B strain)-10^4.3 to 10^6.6 TCID50 Leptospira interrogans ser. Icterohaemorrhagiae (MSLB 1089 strain)- >1:51 ALR (GMT)   ser. Canicola (MSLB 1090 strain)-- >1:51 ALR (GMT)   ser. Bratislava (MSLB 1088 strain)- >1:51 ALR (GMT) Leptospira kirschneri ser. Grippotyphosa (MSLB 1091 strain)- >1:40 ALR (GMT) Rabies Virus (SAD Vnukovo-32 Bio 16 strain)-> 2.0 IU   TCID-Tissue Culture Infect Dose 50% GMT-Geometric Moon Titre ALR-Agglutination Lyuis Reacties Freeze-dried powder for Injection (SC) Philippines - English - FDA (Food And Drug Administration)

biocan novel dhppi l4r formulation: each dose (1 ml) contains: canine distemper virus (cdv bio 11/a strain)- 10^3.1 to 10^5.1 tcid50 canine parainfluenza type 2 virus (cpiv-2-bio 15 strain)-- 10^3.1 to 10^5.1 tcid50 canine adenovirus type 2 (cav-2-bio 13 strain)-10^3.6 to 10^5.3 tcid50 canine parvovirus type 2b (cpv-2b bio 12/b strain)-10^4.3 to 10^6.6 tcid50 leptospira interrogans ser. icterohaemorrhagiae (mslb 1089 strain)- >1:51 alr (gmt) ser. canicola (mslb 1090 strain)-- >1:51 alr (gmt) ser. bratislava (mslb 1088 strain)- >1:51 alr (gmt) leptospira kirschneri ser. grippotyphosa (mslb 1091 strain)- >1:40 alr (gmt) rabies virus (sad vnukovo-32 bio 16 strain)-> 2.0 iu tcid-tissue culture infect dose 50% gmt-geometric moon titre alr-agglutination lyuis reacties freeze-dried powder for injection (sc)

broadchem philippines biopharma corporation; distributor: broadchem philippines biopharma corporation - live attenuated canine distemper virus (cdv) , canine parainfluenza virus , canine adenovirus (cav) , canine parvovirus , inactivated leptospira interrogans ser. icterohaemorrhagiae , l. interrogans ser. canicola , l. kirschneri ser. grippotyphosa , l. interrogans ser. bratislava , rabies virus vaccine (vet.) - freeze-dried powder for injection (sc) - formulation: each dose (1 ml) contains: canine distemper virus (cdv bio 11/a strain)- 10^3.1 to 10^5.1 tcid50 canine parainfluenza type 2 virus (cpiv-2-bio 15 strain)-- 10^3.1 to 10^5.1 tcid50 canine adenovirus type 2 (cav-2-bio 13 strain)-10^3.6 to 10^5.3 tcid50 canine parvovirus type 2b (cpv-2b bio 12/b strain)-10^4.3 to 10^6.6 tcid50 leptospira interrogans ser. icterohaemorrhagiae (mslb 1089 strain)- >1:51 alr (gmt) ser. canicola (mslb 1090 strain)-- >1:51 alr (gmt) ser. bratislava (mslb 1088 strain)- >1:51 alr (gmt) leptospira kirschneri ser. grippotyphosa (mslb 1091 strain)- >1:40 alr (gmt) rabies virus (sad vnukovo-32 bio 16 strain)-> 2.0 iu tcid-tissue culture infect dose 50% gmt-geometric moon titre alr-agglutination lyuis reacties